About
Glenmark Pharmaceuticals Limited, together with its subsidiaries, research, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides various products in the therapeutic areas of dermatology, respiratory, oncology, cardiology, diabetes, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, and respiratory-metered dose inhaler, dry powder inhaler, and nasal sprays. Its product pipeline includes ISB 2001, a CD38 x BCMA x CD3 trispecific T cell engager, which is in Phase 1 clinical trial for indication of multiple myeloma; ISB 2301, a Multispecific Immune Cell Activator that is in preclinical trial for solid tumors; ISB 2302, a bispecific immune modulator with an indication for hematologic and solid tumors; and ISB 2501, a trispecific T-cell engager indicated for solid tumors. The company's pipeline also comprises ISB 880, an IL-1RAP antagonist monoclonal antibody, which is in Phase 2 clinical trial for the treatment of hidradenitis suppurativa; and telazorlimab and ISB 830-X8, a OX40 antagonist mAb for the treatment of atopic dermatitis. In addition, the company offers Ryaltris, fixed-dose nasal spray for the treatment of allergic rhinitis. The company was incorporated in 1977 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap68,789 Cr
P/E22.00
Div Yield0.21 %
Book Value₹372.00
52w High₹2,538.00
52w Low₹1,793.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,435.00 | 2,147.00 | 2,360.00 | 1,539.00 | 2,395.00 | 2,010.00 | 2,251.00 | 2,636.00 | 2,330.00 | 2,148.00 | 1,365.00 | 2,233.00 | 2,144.00 |
| Expenses | 1,822.00 | 2,115.00 | 1,864.00 | 1,717.00 | 1,667.00 | 1,669.00 | 1,757.00 | 1,857.00 | 1,698.00 | 1,651.00 | 1,549.00 | 1,790.00 | 1,659.00 |
| Operating Profit | 613.00 | 32.00 | 496.00 | -178.00 | 728.00 | 341.00 | 494.00 | 779.00 | 631.00 | 497.00 | -184.00 | 443.00 | 485.00 |
| OPM % | 25.00 | 1.50 | 21.00 | -12.00 | 30.00 | 17.00 | 22.00 | 30.00 | 27.00 | 23.00 | -14.00 | 20.00 | 23.00 |
| Other Income | 338.00 | -61.00 | -68.00 | -646.00 | -254.00 | -91.00 | 129.00 | 83.00 | 56.00 | 5,933.00 | 234.00 | 54.00 | 18.00 |
| Depreciation | 62.00 | 60.00 | 59.00 | 59.00 | 58.00 | 56.00 | 55.00 | 55.00 | 53.00 | 52.00 | 51.00 | 50.00 | 49.00 |
| Interest | 23.00 | 18.00 | 22.00 | 23.00 | 15.00 | 13.00 | 8.00 | 12.00 | 15.00 | 83.00 | 74.00 | 58.00 | 62.00 |
| Profit before tax | 866.00 | -107.00 | 347.00 | -906.00 | 401.00 | 181.00 | 559.00 | 795.00 | 618.00 | 6,295.00 | -76.00 | 389.00 | 392.00 |
| Tax % | 15.00 | -31.00 | 19.00 | -18.00 | 18.00 | 18.00 | 26.00 | 25.00 | 27.00 | 27.00 | -73.00 | 22.00 | 31.00 |
| Net Profit | 736.00 | -74.00 | 282.00 | -739.00 | 330.00 | 148.00 | 414.00 | 595.00 | 454.00 | 4,614.00 | -20.00 | 302.00 | 272.00 |
| EPS in Rs | 26.07 | -2.62 | 10.00 | -26.19 | 11.70 | 5.24 | 14.66 | 21.09 | 16.08 | 163.50 | -0.72 | 10.72 | 9.63 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,440.00 | 9,226.00 | 7,891.00 | 8,221.00 | 8,142.00 | 7,568.00 | 6,713.00 | 6,305.00 | 5,520.00 | 7,989.00 | 6,115.00 | 5,086.00 |
| Expenses | 7,361.00 | 6,982.00 | 6,649.00 | 6,748.00 | 6,453.00 | 5,676.00 | 5,407.00 | 4,977.00 | 4,417.00 | 5,089.00 | 4,349.00 | 3,618.00 |
| Operating Profit | 1,079.00 | 2,244.00 | 1,242.00 | 1,473.00 | 1,689.00 | 1,892.00 | 1,305.00 | 1,328.00 | 1,103.00 | 2,900.00 | 1,766.00 | 1,467.00 |
| OPM % | 13.00 | 24.00 | 16.00 | 18.00 | 21.00 | 25.00 | 19.00 | 21.00 | 20.00 | 36.00 | 29.00 | 29.00 |
| Other Income | -1,030.00 | 177.00 | 6,238.00 | 490.00 | 1,044.00 | 469.00 | 624.00 | 954.00 | 326.00 | -89.00 | 116.00 | -86.00 |
| Interest | 79.00 | 49.00 | 277.00 | 207.00 | 236.00 | 266.00 | 256.00 | 224.00 | 191.00 | 153.00 | 36.00 | 30.00 |
| Depreciation | 236.00 | 219.00 | 202.00 | 184.00 | 160.00 | 151.00 | 139.00 | 106.00 | 96.00 | 105.00 | 100.00 | 119.00 |
| Profit before tax | -266.00 | 2,154.00 | 7,001.00 | 1,572.00 | 2,337.00 | 1,944.00 | 1,535.00 | 1,952.00 | 1,143.00 | 2,553.00 | 1,747.00 | 1,232.00 |
| Tax % | -25.00 | 25.00 | 26.00 | 23.00 | 15.00 | 15.00 | 12.00 | 17.00 | 11.00 | 16.00 | 15.00 | 18.00 |
| Net Profit | -201.00 | 1,610.00 | 5,167.00 | 1,209.00 | 1,998.00 | 1,649.00 | 1,355.00 | 1,622.00 | 1,014.00 | 2,141.00 | 1,484.00 | 1,008.00 |
| EPS in Rs | -7.12 | 57.07 | 183.12 | 42.84 | 70.80 | 58.46 | 48.01 | 57.49 | 35.95 | 75.86 | 52.60 | 37.14 |
| Dividend Payout % | -70.00 | 4.00 | 1.00 | 6.00 | 4.00 | 4.00 | 5.00 | 3.00 | 6.00 | 3.00 | 4.00 | 5.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 27.00 |
| Reserves | 24,122.00 | 24,476.00 | 22,942.00 | 17,849.00 | 16,710.00 | 14,781.00 | 13,198.00 | 11,914.00 | 10,363.00 | 9,408.00 | 7,338.00 | 4,925.00 |
| Borrowings | 107.00 | 830.00 | 707.00 | 3,221.00 | 3,738.00 | 3,704.00 | 3,574.00 | 3,134.00 | 2,981.00 | 2,777.00 | 787.00 | 410.00 |
| Other Liabilities | 5,228.00 | 2,700.00 | 3,736.00 | 3,487.00 | 2,438.00 | 2,104.00 | 2,152.00 | 2,066.00 | 1,892.00 | 1,787.00 | 1,960.00 | 2,289.00 |
| Total Liabilities | 29,485.00 | 28,033.00 | 27,414.00 | 24,586.00 | 22,914.00 | 20,618.00 | 18,952.00 | 17,143.00 | 15,265.00 | 14,001.00 | 10,113.00 | 7,651.00 |
| Fixed Assets | 2,028.00 | 1,979.00 | 1,756.00 | 1,746.00 | 1,752.00 | 1,722.00 | 1,612.00 | 1,413.00 | 1,699.00 | 1,596.00 | 1,438.00 | 1,231.00 |
| CWIP | 159.00 | 155.00 | 198.00 | 172.00 | 109.00 | 131.00 | 200.00 | 286.00 | 420.00 | 271.00 | 276.00 | 294.00 |
| Investments | 15,202.00 | 15,195.00 | 12,965.00 | 10,334.00 | 8,559.00 | 6,990.00 | 4,714.00 | 3,269.00 | 3,213.00 | 1,867.00 | 1,858.00 | 1,660.00 |
| Other Assets | 12,096.00 | 10,705.00 | 12,496.00 | 12,334.00 | 12,494.00 | 11,774.00 | 12,426.00 | 12,174.00 | 9,933.00 | 10,267.00 | 6,541.00 | 4,466.00 |
| Total Assets | 29,485.00 | 28,033.00 | 27,414.00 | 24,586.00 | 22,914.00 | 20,618.00 | 18,952.00 | 17,143.00 | 15,265.00 | 14,001.00 | 10,113.00 | 7,651.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 543.00 | 589.00 | -495.00 | 1,474.00 | 1,216.00 | 1,243.00 | 1,579.00 | 2,490.00 | 1,124.00 | 878.00 | 355.00 | 145.00 |
| Cash from Investing Activity | 569.00 | -490.00 | 3,197.00 | -432.00 | -897.00 | -1,235.00 | -1,607.00 | -2,256.00 | -1,137.00 | -2,580.00 | -1,545.00 | -176.00 |
| Cash from Financing Activity | -952.00 | -95.00 | -2,666.00 | -978.00 | -305.00 | -81.00 | -139.00 | -155.00 | -62.00 | 1,879.00 | 1,223.00 | -32.00 |
| Net Cash Flow | 160.00 | 3.00 | 35.00 | 64.00 | 14.00 | -73.00 | -168.00 | 79.00 | -75.00 | 177.00 | 32.00 | -64.00 |
| Free Cash Flow | 266.00 | 249.00 | -690.00 | 1,601.00 | 1,053.00 | 1,112.00 | 1,575.00 | 2,867.00 | 735.00 | 587.00 | 12.00 | -89.00 |
| CFO/OP % | 58.00 | 52.00 | 30.00 | 128.00 | 95.00 | 83.00 | 147.00 | 218.00 | 128.00 | 53.00 | 41.00 | 26.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 143.00 | 101.00 | 115.00 | 111.00 | 120.00 | 120.00 | 100.00 | 121.00 | 253.00 | 177.00 | 182.00 | 175.00 |
| Inventory Days | 153.00 | 156.00 | 130.00 | 117.00 | 102.00 | 94.00 | 115.00 | 141.00 | 195.00 | 172.00 | 182.00 | 161.00 |
| Days Payable | 326.00 | 249.00 | 307.00 | 225.00 | 208.00 | 201.00 | 217.00 | 258.00 | 273.00 | 221.00 | 306.00 | 343.00 |
| Cash Conversion Cycle | -30.00 | 8.00 | -62.00 | 3.00 | 14.00 | 14.00 | -3.00 | 4.00 | 175.00 | 129.00 | 59.00 | -6.00 |
| Working Capital Days | 92.00 | 55.00 | 12.00 | 29.00 | 42.00 | 115.00 | 106.00 | 151.00 | 232.00 | 170.00 | 108.00 | 79.00 |
| ROCE % | 7.00 | 10.00 | 10.00 | 11.00 | 11.00 | 12.00 | 11.00 | 13.00 | 10.00 | 29.00 | 26.00 | 33.00 |
Corporate Actions
25 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 03 Oct 2025 | 03 Oct 2025 | — | 2.50 | |
| Dividend | 15 Sep 2025 | 15 Sep 2025 | — | 2.50 | |
| Dividend | 13 Sep 2024 | — | — | 2.50 | |
| Dividend | 18 Sep 2023 | — | — | 2.50 | |
| Dividend | 12 Sep 2022 | — | — | 2.50 | |
| Dividend | 08 Sep 2021 | — | — | 2.50 | |
| Dividend | 17 Sep 2020 | — | — | 2.50 | |
| Dividend | 19 Sep 2019 | — | — | 2.00 | |
| Dividend | 19 Sep 2018 | — | — | 2.00 | |
| Dividend | 20 Sep 2017 | — | — | 2.00 | |
| Dividend | 03 Aug 2016 | — | — | 2.00 | |
| Dividend | 10 Sep 2015 | — | — | 2.00 | |
| Dividend | 10 Jul 2014 | — | — | 2.00 | |
| Dividend | 18 Jul 2013 | — | — | 2.00 | |
| Dividend | 19 Jul 2012 | — | — | 2.00 | |
| Dividend | 28 Jul 2011 | — | — | 0.40 | |
| Dividend | 16 Sep 2010 | — | — | 0.40 | |
| Dividend | 10 Sep 2009 | — | — | 0.40 | |
| Other | 18 Sep 2008 | — | — | — | Annual General Meeting |
| Dividend | 07 Nov 2007 | 08 Nov 2007 | — | 0.70 | |
| Split | 10 Sep 2007 | — | 2:1 | — | |
| Dividend | 04 Jan 2007 | 05 Jan 2007 | — | 0.40 | |
| Other | 25 Sep 2006 | — | — | — | Agm |
| Other | 22 Sep 2005 | — | — | — | Agm |
| Dividend | 03 Sep 2001 | — | — | 4.00 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update12 Aug from crisil
-
Rating update11 Feb from crisil
-
Rating update18 Sep 2025 from crisil
-
Rating update23 Jul 2025 from fitch
-
Rating update18 Jun 2025 from crisil
-
Rating update25 Apr 2024 from fitch